Protective effects of lithium treatment for spatial memory deficits induced by tau hyperphosphorylation in splenectomized rats

Clin Exp Pharmacol Physiol. 2010 Oct;37(10):1010-5. doi: 10.1111/j.1440-1681.2010.05433.x.

Abstract

1. Postoperative cognitive dysfunction has become more prevalent in recent years. We used a splenectomized rat model with postoperative spatial learning and memory deficits to investigate the role of tau hyperphosphorylation and glycogen synthase kinase-3β (GSK-3β) within the hippocampus. 2. Cognitive function was assessed in a Y-maze 1 day before and 1, 3 and 7 days after surgery. We measured site-specific phosphorylation of hippocampal tau (Thr-205 and Ser-396), GSK-3β activity and expression of interleukin-1β (IL-1β), tumour necrosis factor-α (TNF-α) mRNA and protein as markers of inflammation. We also tested the effects of treatment with lithium chloride (LiCl), a GSK-3β inhibitor. 3. Splenectomy was associated with learning and memory impairment 3 days later, as well as a rapid and massive hyperphosphorylation of hippocampal tau at Thr-205 and Ser-396, activated GSK-3β, and increased IL-1β and TNF-α expression. LiCl completely restored tau hyperphosphorylation to control levels. 4. These data from the splenectomized rat model suggest that inflammatory factors affect tau pathology through the GSK-3β signalling pathway and that LiCl is a promising treatment for postoperative cognitive deficits.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biomarkers / metabolism
  • Glycogen Synthase Kinase 3 / antagonists & inhibitors
  • Glycogen Synthase Kinase 3 / physiology
  • Glycogen Synthase Kinase 3 beta
  • Inflammation Mediators / metabolism
  • Inflammation Mediators / therapeutic use
  • Lithium Chloride / therapeutic use*
  • Male
  • Maze Learning / drug effects
  • Maze Learning / physiology
  • Memory Disorders / metabolism*
  • Memory Disorders / pathology
  • Memory Disorders / prevention & control*
  • Neuroprotective Agents / therapeutic use*
  • Phosphorylation / drug effects
  • Phosphorylation / physiology
  • Postoperative Complications / metabolism
  • Postoperative Complications / pathology
  • Postoperative Complications / prevention & control*
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Splenectomy / adverse effects*
  • Treatment Outcome
  • tau Proteins / metabolism*
  • tau Proteins / physiology

Substances

  • Biomarkers
  • Inflammation Mediators
  • Neuroprotective Agents
  • tau Proteins
  • Glycogen Synthase Kinase 3 beta
  • Gsk3b protein, rat
  • Glycogen Synthase Kinase 3
  • Lithium Chloride